PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products... Show more
The 50-day moving average for PTKFY moved above the 200-day moving average on July 03, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on July 01, 2025. You may want to consider a long position or call options on PTKFY as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PTKFY just turned positive on July 02, 2025. Looking at past instances where PTKFY's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PTKFY advanced for three days, in of 4 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
PTKFY broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.794) is normal, around the industry mean (5.632). P/E Ratio (30.030) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.018) settles around the average of (0.161) among similar stocks. P/S Ratio (3.427) is also within normal values, averaging (3.643).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTKFY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTKFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CCIF | 6.47 | 0.02 | +0.31% |
Carlyle Credit Income Fund | |||
HYGH | 86.42 | 0.18 | +0.21% |
iShares Interest Rate Hdg Hi Yld Bd ETF | |||
CLOB | 50.63 | 0.07 | +0.13% |
VanEck AA-BB CLO ETF | |||
FMNY | 25.98 | N/A | N/A |
First Trust New York High Inc Mncpl ETF | |||
CGMS | 27.61 | -0.01 | -0.04% |
Capital Group U.S. Multi-Sector Inc ETF |
A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.
Ticker / NAME | Correlation To PTKFY | 1D Price Change % | ||
---|---|---|---|---|
PTKFY | 100% | N/A | ||
SNPHF - PTKFY | 6% Poorly correlated | N/A | ||
RHHBF - PTKFY | 6% Poorly correlated | N/A | ||
SNPHY - PTKFY | 0% Poorly correlated | +1.80% | ||
OTSKF - PTKFY | 0% Poorly correlated | N/A | ||
RCDTF - PTKFY | 0% Poorly correlated | N/A | ||
More |